reflecting enhanced growth prospects and a stronger balance sheet. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported a GAAP operating loss of $29 million in Q4 2024, primarily due to a ...

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries ... and continue strengthening our balance sheet. These upgrades are testament of our focused ...

Investing.com – Israel stocks were higher after the close on Wednesday, as gains in the Insurance, Oil & Gas and Financials sectors led shares higher. At the close in Tel Aviv,... Investing.com ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

The Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 1.25% and 1.32%, respectively, in Q3 ...

President Trump's threat of reciprocal tariffs to be levied on trading partners in the months ahead would hit the roughly $600 billion worth of goods imported from European Union member states in ...

Among products the White House cited in a fact sheet as ... "For pharmaceuticals alone, businesses nationwide will be paying $100 million/day in new potential tariffs." Teva Pharmaceuticals ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

1 Day TEVA -5.67% DJIA -0.75% S&P 500 -0.50% Health Care/Life Sciences 0.29% ...